The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study
2025; Frontiers Media; Volume: 12; Linguagem: Inglês
10.3389/fmed.2025.1543272
ISSN2296-858X
AutoresSatoko Sasatsu, Yosuke Ono, Dai Miyashita, T Yoshihara, Kota Tanaka, So Owada, Koji Makino, Akira Nakagomi, Maki Ogi, Eriko Ogasawara, Hikaru Tagaya, Hiroko Fukasawa, Yasuhiko Okuda, Osamu Yoshino,
Tópico(s)Homicide, Infanticide, and Child Abuse
Referência(s)